**J&J’s Medical Device Sales Surge in First Quarter – Wall Street Shocked at Revenue Growth**
Irvine, California – Johnson & Johnson’s medical technology division has seen a surge in demand for its devices used in surgeries, orthopedics, and vision care. This increased demand is attributed to older adults resuming nonurgent surgeries they had postponed during the Covid-19 pandemic. Health insurers like Humana, UnitedHealth Group, and Elevance Health have noted this uptick in demand. In the first quarter of 2024, Johnson & Johnson reported adjusted earnings per share of $2.71, surpassing …